KA/EN
Register
Medicines reference
Search
Search
Product

Evicto

Favourites

Selamectin · Virbac

6 forms: spot-on. In force in Georgia: 6 of 6 (veterinary register).

Forms and doses6 of 6 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
15 mg, Spot-on · Cat up to 2.5 kg Cat up to 2.5 kg 1 pipette
Cats (kg) ≤ 2.5; 1 pipette of Evicto 15 mg; 15; 60; 0.25
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 15მგ
№ 71-11
Verified on: 15 Oct 2026
15 mg, Spot-on · Dog up to 2.5 kg Dog up to 2.5 kg 1 pipette
Dogs (kg) ≤ 2.5; 1 pipette of Evicto 15 mg for cats and dogs ≤2.5 kg; 15; 60; 0.25 a single dose delivering a minimum of 6 mg/kg selamectin
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 15მგ
№ 71-11
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Evicto 15 mg, Spot-on

selamectin 15 mg (60 mg/ml), spot-on solution for cats and dogs up to 2.5 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets
8.4/10
Very good
vetman assessment

Evicto

15 mg, selamectin 15 mg (60 mg/ml), spot-on solution for cats and dogs up to 2.5 kg
Assessed clinical scopeDog · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 71-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • For heartworm prevention, test according to local epidemiology and the exact label; heavily microfilaraemic dogs require veterinary assessment and monitoring for acute reactions.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets
8.4/10
Very good
vetman assessment

Evicto

15 mg, selamectin 15 mg (60 mg/ml), spot-on solution for cats and dogs up to 2.5 kg
Assessed clinical scopeCat · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 71-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • Do not use in cats with concomitant disease or in debilitated or underweight cats unless the exact locally applicable label and a veterinarian-led benefit-risk decision permit use.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Selamectin15 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1043, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 15მგ
№ 71-11
Verified on: 15 Oct 2026
 EU Yes, veterinary
Verified on: 15 Oct 2026
 UK Yes, veterinary
Verified on: 15 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 pipette
Cats (kg) ≤ 2.5; 1 pipette of Evicto 15 mg; 15; 60; 0.25
 Cat up to 2.5 kg On the skin monthly Product label (SPC)
1 pipette
Dogs (kg) ≤ 2.5; 1 pipette of Evicto 15 mg for cats and dogs ≤2.5 kg; 15; 60; 0.25 a single dose delivering a minimum of 6 mg/kg selamectin
 Dog up to 2.5 kg On the skin monthly Product label (SPC)
30 mg, Spot-on · Cat Any weight Cat Any weight No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label. For cats, use the 15 mg or 45 mg pipette (60 mg/mL).
 - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 30მგ
№ 75-11
Verified on: 15 Oct 2026
30 mg, Spot-on · Dog 2.5–5 kg Dog 2.5–5 kg 1 pipette
2.6-5.0; 1 pipette of Evicto 30 mg for dogs 2.6-5.0 kg; 30; 120; 0.25
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 30მგ
№ 75-11
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Evicto 30 mg, Spot-on

selamectin 30 mg (120 mg/ml), spot-on solution for dogs 2.6-5 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Evicto

30 mg, selamectin 30 mg (120 mg/ml), spot-on solution for dogs 2.6-5 kg
Assessed clinical scopeDog · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 75-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • For heartworm prevention, test according to local epidemiology and the exact label; heavily microfilaraemic dogs require veterinary assessment and monitoring for acute reactions.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Selamectin30 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1046, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 30მგ
№ 75-11
Verified on: 15 Oct 2026
 EU Yes, veterinary
Verified on: 15 Oct 2026
 UK Yes, veterinary
Verified on: 15 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label. For cats, use the 15 mg or 45 mg pipette (60 mg/mL).
 Cat Any weight On the skin - Product label (SPC)
1 pipette
2.6-5.0; 1 pipette of Evicto 30 mg for dogs 2.6-5.0 kg; 30; 120; 0.25
 Dog 2.5–5 kg On the skin monthly Product label (SPC)
45 mg, Spot-on · Cat 2.5–7.5 kg Cat 2.5–7.5 kg 1 pipette
2.6-7.5; 1 pipette of Evicto 45 mg for cats 2.6-7.5 kg; 45; 60; 0.75
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 45მგ
№ 78-11
Verified on: 15 Oct 2026
45 mg, Spot-on · Dog Any weight Dog Any weight No dose for this species
This pipette is for cats; no canine dose is provided on the label.
 - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 45მგ
№ 78-11
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Evicto 45 mg, Spot-on

selamectin 45 mg (60 mg/ml), spot-on solution for cats 2.6-7.5 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.4/10
Very good
vetman assessment

Evicto

45 mg, selamectin 45 mg (60 mg/ml), spot-on solution for cats 2.6-7.5 kg
Assessed clinical scopeCat · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 78-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • Do not use in cats with concomitant disease or in debilitated or underweight cats unless the exact locally applicable label and a veterinarian-led benefit-risk decision permit use.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Selamectin45 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1048, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 45მგ
№ 78-11
Verified on: 15 Oct 2026
 EU Yes, veterinary
Verified on: 15 Oct 2026
 UK Yes, veterinary
Verified on: 15 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 pipette
2.6-7.5; 1 pipette of Evicto 45 mg for cats 2.6-7.5 kg; 45; 60; 0.75
 Cat 2.5–7.5 kg On the skin monthly Product label (SPC)
No dose for this species
This pipette is for cats; no canine dose is provided on the label.
 Dog Any weight On the skin - Product label (SPC)
60 mg, Spot-on · Cat Any weight Cat Any weight No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label. Evicto 60 mg for cats weighing 7.6–10 kg is a different 60 mg/mL, 1.0 mL product and is not registered in Georgia.
 - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 60მგ
№ 72-11
Verified on: 15 Oct 2026
60 mg, Spot-on · Dog 5–10 kg Dog 5–10 kg 1 pipette
5.1-10.0; 1 pipette of Evicto 60 mg for dogs 5.1-10.0 kg; 60; 120; 0.5
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 60მგ
№ 72-11
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Evicto 60 mg, Spot-on

selamectin 60 mg (120 mg/ml), spot-on solution for dogs 5.1-10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Evicto

60 mg, selamectin 60 mg (120 mg/ml), spot-on solution for dogs 5.1-10 kg
Assessed clinical scopeDog · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 72-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • For heartworm prevention, test according to local epidemiology and the exact label; heavily microfilaraemic dogs require veterinary assessment and monitoring for acute reactions.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Selamectin60 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1044, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 60მგ
№ 72-11
Verified on: 15 Oct 2026
 EU Yes, veterinary
Verified on: 15 Oct 2026
 UK Yes, veterinary
Verified on: 15 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label. Evicto 60 mg for cats weighing 7.6–10 kg is a different 60 mg/mL, 1.0 mL product and is not registered in Georgia.
 Cat Any weight On the skin - Product label (SPC)
1 pipette
5.1-10.0; 1 pipette of Evicto 60 mg for dogs 5.1-10.0 kg; 60; 120; 0.5
 Dog 5–10 kg On the skin monthly Product label (SPC)
120 mg, Spot-on · Cat Any weight Cat Any weight No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label.
 - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 120მგ
№ 158-11
Verified on: 15 Oct 2026
120 mg, Spot-on · Dog 10–20 kg Dog 10–20 kg 1 pipette
10.1-20.0; 1 pipette of Evicto 120 mg for dogs 10.1-20.0 kg; 120; 120; 1.0
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 120მგ
№ 158-11
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Evicto 120 mg, Spot-on

selamectin 120 mg (120 mg/ml), spot-on solution for dogs 10.1-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Evicto

120 mg, selamectin 120 mg (120 mg/ml), spot-on solution for dogs 10.1-20 kg
Assessed clinical scopeDog · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 158-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • For heartworm prevention, test according to local epidemiology and the exact label; heavily microfilaraemic dogs require veterinary assessment and monitoring for acute reactions.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Selamectin120 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 120მგ
№ 158-11
Verified on: 15 Oct 2026
 EU Yes, veterinary
Verified on: 15 Oct 2026
 UK Yes, veterinary
Verified on: 15 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label.
 Cat Any weight On the skin - Product label (SPC)
1 pipette
10.1-20.0; 1 pipette of Evicto 120 mg for dogs 10.1-20.0 kg; 120; 120; 1.0
 Dog 10–20 kg On the skin monthly Product label (SPC)
240 mg, Spot-on · Cat Any weight Cat Any weight No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label.
 - Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 240მგ
№ 73-11
Verified on: 15 Oct 2026
240 mg, Spot-on · Dog 20–40 kg Dog 20–40 kg 1 pipette
20.1-40.0; 1 pipette of Evicto 240 mg for dogs 20.1-40.0 kg; 240; 120; 2.0
 · monthly		 monthly Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 240მგ
№ 73-11
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Evicto 240 mg, Spot-on

selamectin 240 mg (120 mg/ml), spot-on solution for dogs 20.1-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Evicto

240 mg, selamectin 240 mg (120 mg/ml), spot-on solution for dogs 20.1-40 kg
Assessed clinical scopeDog · Full labelled species-specific scope for treatment or prevention of susceptible flea, mite, nematode and heartworm targets · On the skin
Care settingMonthly or indication-specific single-pipette spot-on treatment after exact species, weight, parasite and heartworm-risk assessment
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 73-11 · Verified on 15 Oct 2026

A well-supported centrally authorised generic with the same established selamectin role and practical dosing; its evidence rests mainly on bioequivalence and the reference product rather than exact-brand outcome trials.

Regulatory and scientific credibility8.5/10

Every exact presentation is registered in Georgia; Evicto has a current central EU/UK generic authorisation supported by satisfactory quality and bioequivalence to Stronghold.

Clinical efficacy8.5/10

Efficacy is bridged to the established selamectin reference product through the generic dossier and bioequivalence; the active has strong field evidence, although independent exact-Evicto outcome trials are limited.

Safety and tolerability8.0/10

The safety margin is well characterised and generally favourable, but species/weight mismatch, very young age, debilitated or underweight cats, wet or damaged skin, ingestion and heavily microfilaraemic dogs require specific precautions.

Clinical practicality8.5/10

A premeasured monthly pipette is simple and avoids oral administration, but correct skin exposure, full-pipette delivery, drying time and prevention of licking are necessary for reliable use.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only the exact species and weight-band pipette; do not split a pipette or substitute dog and cat presentations solely by milligram strength.
  • Do not use below six weeks of age or on wet, broken or otherwise unsuitable application skin; observe the locally applicable exact label.
  • Apply the complete pipette directly to exposed skin, prevent licking and close contact until dry, and keep away from flame or ignition sources during drying.
  • Confirm the target parasite and repeat interval; investigate apparent failure for application technique, bathing, reinfection and resistance rather than empirically increasing dose.
  • For heartworm prevention, test according to local epidemiology and the exact label; heavily microfilaraemic dogs require veterinary assessment and monitoring for acute reactions.
Assessment sources
  1. VMD SPC 20242024
  2. EMA Evicto opinion2019
  3. Selamectin flea/HW field trials2000
  4. Selamectin mite field trials2000
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Selamectin240 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1045, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ევიქტო® 240მგ
№ 73-11
Verified on: 15 Oct 2026
 EU Yes, veterinary
Verified on: 15 Oct 2026
 UK Yes, veterinary
Verified on: 15 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
No dose for this species
This 120 mg/mL pipette is for dogs; no feline dose is provided on the label.
 Cat Any weight On the skin - Product label (SPC)
1 pipette
20.1-40.0; 1 pipette of Evicto 240 mg for dogs 20.1-40.0 kg; 240; 120; 2.0
 Dog 20–40 kg On the skin monthly Product label (SPC)
Active substance doses, with sources
Active substance Selamectin
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
6 mg/kg Dog, Cat Maintenance On the skin monthly
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Stronghold 15 mg spot-on solution for cats and dogs <= 2.5 kg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025

Known Contraindications

  • Critical
    Do not use in animals under 6 weeks of age.
    Sources: VMD SPC · VMD
  • Critical
    Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
    Sources: VMD SPC · VMD
  • Warning (Cat)
    Do not use in cats that are suffering from concomitant disease, or are debilitated and underweight (for size and age).
    Sources: VMD SPC · VMD

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (80 more) Hide additional products

Same therapeutic group 80

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 16 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗